As highlighted in breast cancer, thymic stromal lymphopoietin (TSLP) plays a significant role in the tumor microenvironment, influencing the expansion of CD14+CD16+ monocytes, a subset of immune cells that are involved in inflammation and tissue repair, and modulating cellular metabolism [24]. Here, CD14 is linked to breast carcinoma.